172 related articles for article (PubMed ID: 23454204)
1. Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria.
Baird JK
Travel Med Infect Dis; 2013; 11(1):60-5. PubMed ID: 23454204
[TBL] [Abstract][Full Text] [Related]
2. Primaquine for prevention of malaria in travelers.
Baird JK; Fryauff DJ; Hoffman SL
Clin Infect Dis; 2003 Dec; 37(12):1659-67. PubMed ID: 14689349
[TBL] [Abstract][Full Text] [Related]
3. Review: Malaria chemoprophylaxis for travelers to Latin America.
Steinhardt LC; Magill AJ; Arguin PM
Am J Trop Med Hyg; 2011 Dec; 85(6):1015-24. PubMed ID: 22144437
[TBL] [Abstract][Full Text] [Related]
4. [Two imported and relapsed of Plasmodium vivax malaria cases and primaquine prophylaxis].
Hatipoğlu M; Ulçay A; Turhan V; Karagöz E; Erdem H; Acar A; Oncül O; Görenek L
Turkiye Parazitol Derg; 2014 Jun; 38(2):120-3. PubMed ID: 25016120
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic efficacy of primaquine for preventing Plasmodium falciparum and Plasmodium vivax parasitaemia in travelers: A meta-analysis and systematic review.
Kolifarhood G; Raeisi A; Ranjbar M; Haghdoust AA; Schapira A; Hashemi S; Masoumi-Asl H; Mozafar Saadati H; Azimi S; Khosravi N; Kondrashin A
Travel Med Infect Dis; 2017; 17():5-18. PubMed ID: 28450185
[TBL] [Abstract][Full Text] [Related]
6. Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis.
Shimizu S; Kikuchi T; Koga M; Kato Y; Matsuoka H; Maruyama H; Kimura M;
Travel Med Infect Dis; 2015; 13(3):235-40. PubMed ID: 25482427
[TBL] [Abstract][Full Text] [Related]
7. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
8. [Role of primaquine in malaria control and elimination in French-speaking Africa].
Briolant S; Pradines B; Basco LK
Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
[TBL] [Abstract][Full Text] [Related]
9. Management of relapsing Plasmodium vivax malaria.
Chu CS; White NJ
Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
[TBL] [Abstract][Full Text] [Related]
10. Management of
Baird JK
Trop Dis Travel Med Vaccines; 2017; 3():7. PubMed ID: 28883977
[TBL] [Abstract][Full Text] [Related]
11. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
Milligan R; Daher A; Graves PM
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
[TBL] [Abstract][Full Text] [Related]
12. Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients.
Le Goff M; Kendjo E; Thellier M; Piarroux R; Boelle PY; Jauréguiberry S;
Clin Infect Dis; 2023 Feb; 76(3):e884-e893. PubMed ID: 35962785
[TBL] [Abstract][Full Text] [Related]
13. Status of Plasmodium vivax malaria in the Republic of Korea, 2008-2009: decrease followed by resurgence.
Yeom JS; Jun G; Kim JY; Lee WJ; Shin EH; Chang KS; Bang JH; Oh S; Kang JY; Park JW
Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):429-36. PubMed ID: 22560604
[TBL] [Abstract][Full Text] [Related]
14. The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea.
Ingram RJ; Crenna-Darusallam C; Soebianto S; Noviyanti R; Baird JK
Malar J; 2014 Dec; 13():488. PubMed ID: 25495607
[TBL] [Abstract][Full Text] [Related]
15. Imported tertian malaria resistant to primaquine.
Na DJ; Han JD; Cha DY; Song IK; Choi HW; Chung EA; Park CW; Choi JS
Korean J Intern Med; 1999 Jul; 14(2):86-9. PubMed ID: 10461431
[TBL] [Abstract][Full Text] [Related]
16. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
[TBL] [Abstract][Full Text] [Related]
17. Primaquine treatment and relapse in Plasmodium vivax malaria.
Rishikesh K; Saravu K
Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
[TBL] [Abstract][Full Text] [Related]
18. Recent military experience with malaria chemoprophylaxis.
Rieckmann KH; Yeo AE; Davis DR; Hutton DC; Wheatley PF; Simpson R
Med J Aust; 1993 Apr; 158(7):446-9. PubMed ID: 8469191
[TBL] [Abstract][Full Text] [Related]
19. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
Schwartz E; Regev-Yochay G
Clin Infect Dis; 1999 Dec; 29(6):1502-6. PubMed ID: 10585803
[TBL] [Abstract][Full Text] [Related]
20. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.
Commons RJ; Simpson JA; Thriemer K; Humphreys GS; Abreha T; Alemu SG; Añez A; Anstey NM; Awab GR; Baird JK; Barber BE; Borghini-Fuhrer I; Chu CS; D'Alessandro U; Dahal P; Daher A; de Vries PJ; Erhart A; Gomes MSM; Gonzalez-Ceron L; Grigg MJ; Heidari A; Hwang J; Kager PA; Ketema T; Khan WA; Lacerda MVG; Leslie T; Ley B; Lidia K; Monteiro WM; Nosten F; Pereira DB; Phan GT; Phyo AP; Rowland M; Saravu K; Sibley CH; Siqueira AM; Stepniewska K; Sutanto I; Taylor WRJ; Thwaites G; Tran BQ; Tran HT; Valecha N; Vieira JLF; Wangchuk S; William T; Woodrow CJ; Zuluaga-Idarraga L; Guerin PJ; White NJ; Price RN
Lancet Infect Dis; 2018 Sep; 18(9):1025-1034. PubMed ID: 30033231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
